 LA JOLLA, Calif., March 5, 2021 PRNewswire -- Regulus Therapeutics Inc. Nasdaq: RGLS, a biopharmaceutical company focused on the discovery and development of innovative medicines targeting microRNAs Regulus, today announced that Jay Hagan, President and Chief Executive Officer of... 